A Phase 4 interventional study of Lactated Ringer and Hydroxyethylstarch in Disorders of Coagulation, sponsored by K. C. Rasmussen. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-12-11.
Sponsored by K. C. Rasmussen · Phase 4, Interventional, and Treatment
The purpose of this study is to investigate the effect of thin fluid with starch versus thin fluid without starch on coagulation in elective surgery when the patient is normovolæmic during operation.
The primary goal is to register coagulation on basis of blood samples inclusive thromboelastography results.
The secondary goal is to register blood loss and use of blood products during operation.
The trial concerns 40 patients.
515 studies on the registry are indexed under Hemostatic Disorders; 72 are open to participants now.
This study's planned enrollment of 40 is below the median of 52 across 261 interventional studies indexed under Hemostatic Disorders.
Browse Hemostatic Disorders studies →K. C. Rasmussen is the lead sponsor of 2 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Fluid therapy during operation
Drug: Lactated Ringer · Drug: Hydroxyethylstarch
When normovolæmic status of the patient is secured, 35 ml/kg of the allocated fluid is infused during the operation (estimated time for this type of operation is 180 minutes), however max. 3500 ml.Lactated Ringer is the interventional medication.
Estimate coagulation on basis of bloodsamples
Time frame: 6 months
Estimate coagulation by bloodloss and need for transfusion
Time frame: 6 months
No study locations are listed for this record.
This study is completed, as verified in Dec 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Ringer's Lactate
K. C. Rasmussen